News Low-Contrast Visual Tests Reveal Better Alemtuzumab Efficacy by Medscape • 2013/10/08 • 0 Comments Standard visual acuity testing misses some visual dysfunction in patients with MS. Sloan low-contrast acuity testing revealed superior efficacy for alemtuzumab over interferon beta-1a in CARE-MS I. Medscape Medical News Full Story →